Schizophrenia medication side effects
Pro Research Analysisby 
Searched over 200M research papers
Schizophrenia Medication Side Effects: Impact on Adherence and Quality of Life
Prevalence and Types of Side Effects
Antipsychotic medications, essential for managing schizophrenia, often come with a range of side effects. A significant majority of patients report experiencing at least one side effect, with common issues including sedation, cognitive impairment, metabolic changes, and extrapyramidal symptoms (EPS)1 4. These side effects can vary widely among individuals, with some patients experiencing more severe reactions than others6.
Impact on Medication Adherence
General Non-Adherence
Non-adherence to antipsychotic medication is a prevalent issue among individuals with schizophrenia, often leading to relapse and increased healthcare utilization. Studies have shown that side effects are a major factor contributing to non-adherence. For instance, a nationwide survey found that only 42.5% of patients reported complete adherence to their medication regimen, with side effects significantly reducing the likelihood of adherence1. Another study highlighted that around 20% of participants had missed their medication at least once in the previous week, although the level of accumulated side effects was not directly associated with medication omission2.
Specific Side Effects and Adherence
Certain side effects are more strongly associated with non-adherence. For example, clusters of side effects such as EPS/agitation, sedation/cognition, prolactin/endocrine, and metabolic issues have been linked to lower adherence rates1. Additionally, weight gain and metabolic side effects, which are common with many antipsychotics, significantly impact patients' willingness to continue their medication5 10.
Quality of Life and Functioning
Physical and Psychological Impact
Side effects from antipsychotic medications can severely impact the quality of life and daily functioning of patients. Common side effects such as daytime sleepiness, difficulty sleeping, dry mouth, sexual dysfunction, and weight gain have been reported to affect physical, social, occupational, and psychological aspects of life4. These side effects often lead to frustration and a lower overall satisfaction with life, as indicated by lower scores on quality of life assessments4.
Age and Gender Differences
The prevalence and impact of side effects can also vary based on age and gender. Older patients are more likely to experience anticholinergic and allergic side effects, while younger women are more prone to hormone-related side effects2. Women, in general, report higher incidences of daytime sleepiness, sexual dysfunction, and weight gain compared to men4.
Strategies for Managing Side Effects
Personalized Medicine
Given the variability in side effect profiles among different antipsychotics and individual patients, personalized medicine approaches are recommended. Tailoring treatment plans to the specific needs and side effect profiles of patients can help improve adherence and overall outcomes6. This includes considering patient preferences and concerns about side effects when prescribing medications10.
Monitoring and Training
Regular monitoring of side effects and providing additional training for service users, case managers, and prescribers can help in early identification and management of side effects. This proactive approach can mitigate the negative impact of side effects on adherence and quality of life2.
Conclusion
Side effects of antipsychotic medications are a significant concern for patients with schizophrenia, affecting both adherence to treatment and quality of life. Addressing these side effects through personalized treatment plans, regular monitoring, and patient education is crucial for improving adherence and overall patient outcomes. By understanding and managing the side effects effectively, healthcare providers can help patients achieve better control over their symptoms and enhance their quality of life.
Sources and full results
Most relevant research papers on this topic
A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia
Medication side effects are highly prevalent in schizophrenia patients and significantly associated with medication nonadherence, leading to increased healthcare resource use.
Observational Study
Rigorous Journal
Highly CitedSubjective side effects of antipsychotics and medication adherence in people with schizophrenia.
Antipsychotic medication side effects are common in schizophrenia patients, but medication adherence and side effects are not significantly correlated.
Observational StudyMedication effects: Conceptual and methodological issues in schizophrenia research
Neuroleptic and anticholinergic medication side effects in schizophrenia research must be considered as potential confounds, and strategies to assess, control for, or avoid these effects are discussed.
Literature ReviewThe impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: a worldwide, cross-sectional, web-based survey
Second-generation antipsychotics in schizophrenia patients cause numerous side effects, affecting daily functioning and quality of life, with more severe side effects leading to lower satisfaction.
Observational StudyRigorous JournalMetabolic side effects in persons with schizophrenia during mid‐ to long‐term treatment with antipsychotics: a network meta‐analysis of randomized controlled trials
Antipsychotic drugs differ in their propensity to induce metabolic side effects in mid- to long-term treatment for schizophrenia.
Meta-AnalysisExamining Side Effect Variability of Antipsychotic Treatment in Schizophrenia Spectrum Disorders: A Meta-analysis of Variance.
Antipsychotic side effects in schizophrenia spectrum disorders show increased variability, suggesting stratified or personalized medicine may be beneficial for subgroups or individual patients.
Meta-AnalysisRigorous JournalEfficacy, acceptability and tolerability of antipsychotics in patients with schizophrenia and comorbid substance use. A systematic review and meta-analysis
Clozapine is superior for reducing substance use and risperidone for craving in patients with schizophrenia and comorbid substance use, but firm conclusions can't be drawn due to small sample sizes and insufficient reporting.
Meta-AnalysisMetabolic side effects of antipsychotic drugs in individuals with schizophrenia during medium- to long-term treatment: protocol for a systematic review and network meta-analysis of randomized controlled trials
Antipsychotic drugs differ in their potential for metabolic side effects during medium- to long-term treatment for schizophrenia.
Meta-Analysis
Very Rigorous JournalSide‐effects of antipsychotic medication and health‐related quality of life in schizophrenia
Antipsychotic medication side-effects are associated with lower mental and physical quality of life in schizophrenia patients.
Observational StudyPatient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia
Patients with schizophrenia spectrum disorders prioritize efficacy and side effects when considering antipsychotic medication, with weight gain, physical restlessness, and somnolence being key concerns.
Observational StudyRigorous Journal